Sutro Biopharma, a developer of proteins for cancer therapies, has closed the $16.5 million second tranche of its Series C funding led by Skyline Ventures. The first tranche, of $20 million, was raised in November 2010. Since its founding in 2003, the company has raised a total of $58.6 million in Series A through C financings.
